306 related articles for article (PubMed ID: 34964688)
21. H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas.
Cao T; Jiang Y; Wang Z; Zhang N; Al-Hendy A; Mamillapalli R; Kallen AN; Kodaman P; Taylor HS; Li D; Huang Y
Oncogene; 2019 Jul; 38(27):5356-5366. PubMed ID: 31089260
[TBL] [Abstract][Full Text] [Related]
22. SOGC clinical practice guidelines. Uterine fibroid embolization (UFE). Number 150, October 2004.
Society of Obstetricians and Gynaecologists of Canada
Int J Gynaecol Obstet; 2005 Jun; 89(3):305-18. PubMed ID: 16001461
[TBL] [Abstract][Full Text] [Related]
23. EMAS position statement: management of uterine fibroids.
Pérez-López FR; Ornat L; Ceausu I; Depypere H; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M;
Maturitas; 2014 Sep; 79(1):106-16. PubMed ID: 24975954
[TBL] [Abstract][Full Text] [Related]
24. Loss of stiffness in collagen-rich uterine fibroids after digestion with purified collagenase Clostridium histolyticum.
Jayes FL; Liu B; Moutos FT; Kuchibhatla M; Guilak F; Leppert PC
Am J Obstet Gynecol; 2016 Nov; 215(5):596.e1-596.e8. PubMed ID: 27177523
[TBL] [Abstract][Full Text] [Related]
25. Uterine fibroids.
Stewart EA; Laughlin-Tommaso SK; Catherino WH; Lalitkumar S; Gupta D; Vollenhoven B
Nat Rev Dis Primers; 2016 Jun; 2():16043. PubMed ID: 27335259
[TBL] [Abstract][Full Text] [Related]
26. The study of MED12 gene mutations in uterine leiomyomas from Iranian patients.
Sadeghi S; Khorrami M; Amin-Beidokhti M; Abbasi M; Kamalian Z; Irani S; Omrani M; Azmoodeh O; Mirfakhraie R
Tumour Biol; 2016 Feb; 37(2):1567-71. PubMed ID: 26298726
[TBL] [Abstract][Full Text] [Related]
27. Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas.
Mäkinen N; Vahteristo P; Bützow R; Sjöberg J; Aaltonen LA
Int J Cancer; 2014 Feb; 134(4):1008-12. PubMed ID: 23913526
[TBL] [Abstract][Full Text] [Related]
28. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study.
Hirst A; Dutton S; Wu O; Briggs A; Edwards C; Waldenmaier L; Maresh M; Nicholson A; McPherson K
Health Technol Assess; 2008 Mar; 12(5):1-248, iii. PubMed ID: 18331704
[TBL] [Abstract][Full Text] [Related]
29. MED12 mutation frequency in unselected sporadic uterine leiomyomas.
Heinonen HR; Sarvilinna NS; Sjöberg J; Kämpjärvi K; Pitkänen E; Vahteristo P; Mäkinen N; Aaltonen LA
Fertil Steril; 2014 Oct; 102(4):1137-42. PubMed ID: 25108465
[TBL] [Abstract][Full Text] [Related]
30. Altered chromatin landscape and enhancer engagement underlie transcriptional dysregulation in MED12 mutant uterine leiomyomas.
Moyo MB; Parker JB; Chakravarti D
Nat Commun; 2020 Feb; 11(1):1019. PubMed ID: 32094355
[TBL] [Abstract][Full Text] [Related]
31. A single baseline ultrasound assessment of fibroid presence and size is strongly predictive of future uterine procedure: 8-year follow-up of randomly sampled premenopausal women aged 35-49 years.
Baird DD; Saldana TM; Shore DL; Hill MC; Schectman JM
Hum Reprod; 2015 Dec; 30(12):2936-44. PubMed ID: 26409013
[TBL] [Abstract][Full Text] [Related]
32. MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups.
Markowski DN; Bartnitzke S; Löning T; Drieschner N; Helmke BM; Bullerdiek J
Int J Cancer; 2012 Oct; 131(7):1528-36. PubMed ID: 22223266
[TBL] [Abstract][Full Text] [Related]
33. Multiomic analysis of uterine leiomyomas in self-described Black and White women: molecular insights into health disparities.
Bateman NW; Abulez T; Tarney CM; Bariani MV; Driscoll JA; Soltis AR; Zhou M; Hood BL; Litzi T; Conrads KA; Jackson A; Oliver J; Ganakammal SR; Schneider F; Dalgard CL; Wilkerson MD; Smith B; Borda V; O'Connor T; Segars J; Shobeiri SA; Phippen NT; Darcy KM; Al-Hendy A; Conrads TP; Maxwell GL
Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38723985
[TBL] [Abstract][Full Text] [Related]
34. Medical treatment of uterine leiomyoma.
Sabry M; Al-Hendy A
Reprod Sci; 2012 Apr; 19(4):339-53. PubMed ID: 22378865
[TBL] [Abstract][Full Text] [Related]
35. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
Schwetye KE; Pfeifer JD; Duncavage EJ
Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
[TBL] [Abstract][Full Text] [Related]
36. Alternatives to hysterectomy: The burden of fibroids and the quality of life.
Fortin C; Flyckt R; Falcone T
Best Pract Res Clin Obstet Gynaecol; 2018 Jan; 46():31-42. PubMed ID: 29157931
[TBL] [Abstract][Full Text] [Related]
37. Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution.
Moravek MB; Bulun SE
Curr Opin Obstet Gynecol; 2015 Aug; 27(4):276-83. PubMed ID: 26107781
[TBL] [Abstract][Full Text] [Related]
38. Intra-abdominal haemorrhage from uterine fibroids: a systematic review of the literature.
Lim WH; Cohen SC; Lamaro VP
BMC Surg; 2020 Apr; 20(1):70. PubMed ID: 32293414
[TBL] [Abstract][Full Text] [Related]
39. Profibrotic interleukin-33 is correlated with uterine leiomyoma tumour burden.
Santulli P; Even M; Chouzenoux S; Millischer AE; Borghese B; de Ziegler D; Batteux F; Chapron C
Hum Reprod; 2013 Aug; 28(8):2126-33. PubMed ID: 23739220
[TBL] [Abstract][Full Text] [Related]
40. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.
Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A
Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
